Strong impact of micrometastatic tumor cell load in patients with esophageal carcinoma

Annals of Surgical Oncology

Volumn 16, Issue 2, 2009, Pages 454-462

  Koenig, Alexandra M ^a   Prenzel, Klaus L ^b   Bogoevski, Dean ^a   Yekebas, Emre F ^a   Bubenheim, Michael ^a   Faithova, Lucia ^a   Vashist, Yogesh K ^a   Gawad, Karim A ^a   Baldus, Stephan E ^b   Pantel, Klaus ^a   Schneider, Paul M ^b   Hölscher, Arnulf H ^b   Izbicki, Jakob R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; TUMOR CELL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 59449103759     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0169-7     Document Type: Article

References (41)

1. RT Greenlee MB Hill-Harmon T Murray 2001 Cancer statistics 2001 CA Cancer J Clin 51 15 36
2. P Boyle J Ferlay 2005 Cancer incidence and mortality in Europe, 2004 Ann Oncol 16 481 8
3. K Pantel RH Brakenhoff 2004 Dissecting the metastatic cascade Nat Rev Cancer 4 448 56
4. J Byrne R Waldron D McAvinchey 1987 The use of monoclonal antibodies for the histopathological detection of mammary axillary micrometastases Eur J Surg Oncol 13 409 11
5. B Passlick JR Izbicki B Kubuschok 1994 Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer J Clin Oncol 12 1827 32
6. WA Raymond AS Leong 1989 Immunoperoxidase staining in the detection of lymph node metastases in stage I breast cancer Pathology 21 11 5
7. U Latza G Niedobitek R Schwarting 1990 Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial J Clin Pathol 43 213 9
8. P Hermanek RV Hutter LH Sobin 1999 International Union Against Cancer. Classification of isolated tumor cells and micrometastasis Cancer 86 2668 73
9. JR Izbicki SB Hosch U Pichlmeier 1997 Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer N Engl J Med 337 1188 94
10. SB Hosch NH Stoecklein U Pichlmeier 2001 Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance J Clin Oncol 19 1970 5
11. S Komukai T Nishimaki T Suzuki 2002 Significance of immunohistochemical nodal micrometastasis as a prognostic indicator in potentially curable oesophageal carcinoma Br J Surg 89 213 9
12. TA Waterman JA Hagen JH Peters 2004 The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma Ann Thorac Surg 78 1161 9 discussion 1161-9
13. G Bussolati P Gugliotta I Morra 1986 The immunohistochemical detection of lymph node metastases from infiltrating lobular carcinoma of the breast Br J Cancer 54 631 6
14. ZL Chen S Perez EC Holmes 1993 Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma J Natl Cancer Inst 85 493 8
15. I de Mascarel F Bonichon JM Coindre 1992 Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up Br J Cancer 66 523 7
16. F Momburg G Moldenhauer GJ Hammerling 1987 Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues Cancer Res 47 2883 91
17. K Pantel G Schlimok M Angstwurm 1994 Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow J Hematother 3 165 73
18. K Z'Graggen BA Centeno C Fernandez-del Castillo 2001 Biological implications of tumor cells in blood and bone marrow of pancreatic cancer patients Surgery 129 537 46
19. M Kasper P Stosiek H Typlt 1987 Histological evaluation of three new monoclonal anti-cytokeratin antibodies. 1. Normal tissues Eur J Cancer Clin Oncol 23 137 47
20. D Bogoevski EF Yekebas P Schurr 2004 Mode of spread in the early phase of lymphatic metastasis in pancreatic ductal adenocarcinoma: prognostic significance of nodal microinvolvement Ann Surg 240 993 1000 discussion 1000-1
21. N Martini BJ Flehinger MB Zaman 1983 Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases Ann Surg 198 386 97
22. AG Casson VW Rusch RJ Ginsberg 1994 Lymph node mapping of esophageal cancer Ann Thorac Surg 58 1569 70
23. Hermanek PSL. TNM Classification of Malignant Tumors. New York: Springer, 2002
24. SE Baldus TK Zirbes S Engel 1998 Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas Int J Cancer 79 133 8
25. Klein JPMM. Survival Analysis: Techniques for Censored and Truncated Data. New York: Springer, 1997
26. Cox D. Regression models and life tables (with discussion). J R Stat Soc 1972; 187-220
27. EF Yekebas PG Schurr JT Kaifi 2006 Effectiveness of radical en-bloc-esophagectomy compared to transhiatal esophagectomy in squamous cell cancer of the esophagus is influenced by nodal micrometastases J Surg Oncol 93 541 9
28. SB Hosch WT Knoefel S Metz 1997 Early lymphatic tumor cell dissemination in pancreatic cancer: frequency and prognostic significance Pancreas 15 154 9
29. AS Knisely 1998 Cryptic tumor cells in lymph nodes of patients with esophageal cancer N Engl J Med 338 550
30. GW Clark JH Peters AP Ireland 1994 Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma Ann Thorac Surg 58 646 53 discussion 653-4
31. FH Ellis Jr GJ Heatley MJ Krasna 1997 Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria J Thorac Cardiovasc Surg 113 836 46 discussion 846-8
32. MA Eloubeidi R Desmond MR Arguedas 2002 Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status Cancer 95 1434 43
33. Y Gu SG Swisher JA Ajani 2006 The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation Cancer 106 1017 25
34. JA Hagen SR DeMeester JH Peters 2001 Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies Ann Surg 234 520 30 discussion 530-1
35. AH Holscher E Bollschweiler R Bumm 1995 Prognostic factors of resected adenocarcinoma of the esophagus Surgery 118 845 55
36. T Matsubara M Ueda O Yanagida 1994 How extensive should lymph node dissection be for cancer of the thoracic esophagus? J Thorac Cardiovasc Surg 107 1073 8
37. S Natsugoe H Yoshinaka M Shimada 2001 Number of lymph node metastases determined by presurgical ultrasound and endoscopic ultrasound is related to prognosis in patients with esophageal carcinoma Ann Surg 234 613 8
38. JJ Nigro SR DeMeester JA Hagen 1999 Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy J Thorac Cardiovasc Surg 117 960 8
39. JD Roder R Busch HJ Stein 1994 Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus Br J Surg 81 410 3
40. A Marchet S Mocellin A Ambrosi 2008 The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series Eur J Surg Oncol 34 159 65
41. A Marchet S Mocellin A Ambrosi 2007 The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients Ann Surg 245 543 52